動態

• 

  Mary Grace N. Tamio   shared news

  在 August 09 2023 at 04:45 PM 已編輯 public

  Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2
  
  #eptinezumab #chronicmigraine #journals #articles
  
  More info | ⬇️

  

  Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2

  For assistance, please contact:AAN Members (800) 879-1960 or (612) 928-6000 (International)Non-AAN Member subscribers...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享